Suppr超能文献

F105的Fab片段结构,F105是一种广泛反应性的抗人类免疫缺陷病毒(HIV)抗体,可识别1型HIV gp120的CD4结合位点。

Structure of the Fab fragment of F105, a broadly reactive anti-human immunodeficiency virus (HIV) antibody that recognizes the CD4 binding site of HIV type 1 gp120.

作者信息

Wilkinson Royce A, Piscitelli Chayne, Teintze Martin, Cavacini Lisa A, Posner Marshall R, Lawrence C Martin

机构信息

Department of Chemistry and Biochemistry, Montana State University, Bozeman, 59717, USA.

出版信息

J Virol. 2005 Oct;79(20):13060-9. doi: 10.1128/JVI.79.20.13060-13069.2005.

Abstract

We have determined the crystal structure of the Fab fragment from F105, a broadly reactive human antibody with limited potency that recognizes the CD4 binding site of gp120. The structure reveals an extended CDR H3 loop with a phenylalanine residue at the apex and shows a striking pattern of serine and tyrosine residues. Modeling the interaction between gp120 and F105 suggests that the phenylalanine may recognize the binding pocket of gp120 used by Phe(43) of CD4 and that numerous tyrosine and serine residues form hydrogen bonds with the main chain atoms of gp120. A comparison of the F105 structure to that of immunoglobulin G1 b12, a much more potent and broadly neutralizing antibody with an overlapping epitope, suggests similarities that contribute to the broad recognition of human immunodeficiency virus by both antibodies. While the putative epitope for F105 shows significant overlap with that predicted for b12, it appears to differ from the b12 epitope in extending across the interface between the inner and outer domains of gp120. In contrast, the CDR loops of b12 appear to interact predominantly with the outer domain of gp120. The difference between the predicted epitopes for b12 and F105 suggests that the unique potency of b12 may arise from its ability to avoid the interface between the inner and outer domains of gp120.

摘要

我们已经确定了F105的Fab片段的晶体结构,F105是一种广泛反应但效力有限的人源抗体,可识别gp120的CD4结合位点。该结构显示出一个延伸的CDR H3环,顶端有一个苯丙氨酸残基,并呈现出丝氨酸和酪氨酸残基的显著模式。对gp120与F105之间相互作用的建模表明,苯丙氨酸可能识别CD4的Phe(43)所使用的gp120的结合口袋,并且许多酪氨酸和丝氨酸残基与gp120的主链原子形成氢键。将F105的结构与免疫球蛋白G1 b12(一种具有重叠表位的效力更强且广泛中和的抗体)的结构进行比较,发现了有助于两种抗体广泛识别人类免疫缺陷病毒的相似性。虽然F105的推定表位与预测的b12表位有显著重叠,但它似乎在延伸穿过gp120内外结构域之间的界面方面与b12表位不同。相比之下,b12的CDR环似乎主要与gp120的外结构域相互作用。b12和F105预测表位之间的差异表明,b12的独特效力可能源于其避免gp120内外结构域之间界面的能力。

相似文献

3
Structural mimicry of CD4 by a cross-reactive HIV-1 neutralizing antibody with CDR-H2 and H3 containing unique motifs.
J Mol Biol. 2006 Mar 17;357(1):82-99. doi: 10.1016/j.jmb.2005.12.062. Epub 2006 Jan 9.
7
Structural basis of immune evasion at the site of CD4 attachment on HIV-1 gp120.
Science. 2009 Nov 20;326(5956):1123-7. doi: 10.1126/science.1175868.
8
Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design.
Science. 2001 Aug 10;293(5532):1155-9. doi: 10.1126/science.1061692.
9
Increasing the potency and breadth of an HIV antibody by using structure-based rational design.
Science. 2011 Dec 2;334(6060):1289-93. doi: 10.1126/science.1213782. Epub 2011 Oct 27.
10
Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing.
Science. 2011 Sep 16;333(6049):1593-602. doi: 10.1126/science.1207532. Epub 2011 Aug 11.

引用本文的文献

1
3
Ibalizumab Targeting CD4 Receptors, An Emerging Molecule in HIV Therapy.
Front Microbiol. 2017 Nov 27;8:2323. doi: 10.3389/fmicb.2017.02323. eCollection 2017.
6
A High Throughput Protein Microarray Approach to Classify HIV Monoclonal Antibodies and Variant Antigens.
PLoS One. 2015 May 4;10(5):e0125581. doi: 10.1371/journal.pone.0125581. eCollection 2015.
8
Targeting strategies for delivery of anti-HIV drugs.
J Control Release. 2014 Oct 28;192:271-83. doi: 10.1016/j.jconrel.2014.08.003. Epub 2014 Aug 10.
9

本文引用的文献

1
Processing of X-ray diffraction data collected in oscillation mode.
Methods Enzymol. 1997;276:307-26. doi: 10.1016/S0076-6879(97)76066-X.
2
[Model phases: probabilities and bias.
Methods Enzymol. 1997;277:110-28. doi: 10.1016/s0076-6879(97)77009-5.
3
Structure of an unliganded simian immunodeficiency virus gp120 core.
Nature. 2005 Feb 24;433(7028):834-41. doi: 10.1038/nature03327.
4
Improved design of an antigen with enhanced specificity for the broadly HIV-neutralizing antibody b12.
Protein Eng Des Sel. 2004 Oct;17(10):749-58. doi: 10.1093/protein/gzh085. Epub 2004 Nov 12.
6
Synthetic antibodies from a four-amino-acid code: a dominant role for tyrosine in antigen recognition.
Proc Natl Acad Sci U S A. 2004 Aug 24;101(34):12467-72. doi: 10.1073/pnas.0401786101. Epub 2004 Aug 11.
8
HIV vaccine design and the neutralizing antibody problem.
Nat Immunol. 2004 Mar;5(3):233-6. doi: 10.1038/ni0304-233.
9
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120.
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2706-11. doi: 10.1073/pnas.0308527100. Epub 2004 Feb 23.
10
Structural rationale for the broad neutralization of HIV-1 by human monoclonal antibody 447-52D.
Structure. 2004 Feb;12(2):193-204. doi: 10.1016/j.str.2004.01.003.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验